Recruiting Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer NCT05072600 Conditions Bladder Cancer, Bladder Neoplasms, Bladder Tumors, +13 more Locations Peking University First Hospital — Beijing, Beijing Municipality, China View Trial Details
Completed Study of ESG401 in Adults With Solid Tumors NCT04892342 Conditions Adnexal Diseases, Breast Diseases, Breast Neoplasms, +43 more Locations Cancer Hospital Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China Tianjin Medical University Cancer Institute & Hospital — Tianjin, Tianjin Municipality, China The Second Affiliated Hospital Zhejiang University School of Medicine — Hangzhou, Zhejiang, China View Trial Details